Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $1.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1.9M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $73.01
- 52-wk high
- $97.00
- High
- $73.84
- 52-wk low
- $69.58
- Low
- $72.37
- Prev close
- $72.62
- Mkt cap
- $1.67B
- P/E
- 15.8x
- Volume
- 384.0K
- Fwd P/E
- 7.1x
- Beta
- 0.45
- P/S
- 1.7x
- P/B
- 2.9x
- Profit margin
- +11.1%
- Op margin
- +15.0%
- ROE
- +20.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ANIP filings
Are insiders buying or selling ANI Pharmaceuticals Inc (ANIP) stock?
Net selling: insiders sold $1.9M and bought $0 of ANIP stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $1.6M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Lalwani, Nikhil (President & CEO), who sold $785K. The latest filing was on Sep 30, 2026.
Which members of Congress have traded ANIP recently?
None. No member of Congress disclosed a ANIP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ANIP smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BO

Bank of America
$8.0M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in ANIP right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 9.0% above what analysts expected.
Earnings per share
$1.67 expected
Reports Nov 6, 2026, in 36 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $227.8M | $247.1M | $237.5M | $266.0M |
| Cost of what it sold | $116.0M | $9.5M | $114.5M | $100.2M |
| Gross profit | $111.8M | $237.6M | $123.0M | $165.9M |
| What it spent | ||||
| Research and development | $12.3M | $12.3M | $10.6M | $14.7M |
| Sales and admin | $76.7M | $76.5M | $73.7M | $91.7M |
| Other operating costs | — | $100.6M | — | $19.0M |
| Total operating expenses | $89.0M | $189.4M | $84.3M | $125.4M |
| What was left | ||||
| Operating profit | $22.8M | $48.2M | $38.7M | $40.5M |
| Interest on debt | $4.7M | $22.8M | $3.8M | $3.6M |
| Profit before tax | $33.8M | $31.5M | $40.2M | $37.1M |
| Tax | $7.2M | $4.0M | $10.7M | $12.4M |
| Net profit | $24.1M | $27.5M | $29.5M | $24.7M |
| EBITDA | $61.2M | $76.9M | $57.4M | $60.4M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
35 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace